1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Outcomes for CEA and CAS groups
Outcome (%)CAS (n = 14)CEA (n = 25)P Value
Restenosis2/10 (20%)4/23 (17.4%)1.0
Follow-up intervention1 (7%)3 (12%)1.0
Vessel maturation11 (79%)21 (84%)0.7
Perioperative complication0 (0%)a; 1/17 (5.9%)1 (4%)a; 1/28 (3.6%)1.0a; 1.0
Stroke/MI/death at 1 yr1 (7%)0 (0%).36
  • Note:—MI indicates myocardial infarction.
  • ↵a Perioperative complication rates after including an additional 6 patients (CAS = 3, CEA = 3) who were otherwise excluded from analyses due to insufficient follow-up.